CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
CareDx (CDNA) Tops Q3 EPS by 6c
October 28, 2021 4:02 PM EDTCareDx (NASDAQ: CDNA) reported Q3 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $75.6 million versus the consensus estimate of $74.05 million.
GUIDANCE:
CareDx sees FY2021 revenue of $290-293 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
... More


